The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $499,313 in first-year total cost, median $249,657.
Most frequent study sections
- Cellular and Molecular Immunology - B Study Section[CMIB]1
- Innate Immunity and Inflammation Study Section[III]1
Most frequent institutions
- ROCKEFELLER UNIVERSITY1
- UT SOUTHWESTERN MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Autosomal dominant OTULIN deficiency and staphylococcal disease1R21AI159728-01A1 | BOISSON, BERTRANDSPAAN, ANDRAS NIKO | ROCKEFELLER UNIVERSITY, NY | $254,250 | III |
| 2020 | RNA Surveillance in B cell by the Mammalian Cytoplasmic RNA Exosome1R21AI153576-01 | YAN, NAN | UT SOUTHWESTERN MEDICAL CENTER, TX | $245,063 | CMIB |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.